Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Aridis Pharmaceuticals' cystic fibrosis drug earns orphan designation in Europe

Proactive Investors Friday, 19 July 2019
Aridis Pharmaceuticals Inc (NASDAQ:ARDS) announced Friday that its inhaled treatment for lung infections caused by cystic fibrosis has been granted Orphan Drug Designation by the European Medicines Agency (EMA). Orphan Drug Designation is awarded to companies developing treatments for life-threatening or debilitating conditions that affect fewer than 1 in 10,000 people. It affords Aridis a 10-year period of exclusive marketing for its drug AR-501 in the European Union and reduced fees from the EMA during product development. In June, the drug earned a similar orphan status from the US Food and Drug Administration. READ: Aridis Pharmaceuticals poised for readout of top-line data for its flagship AR-105 treatment in 3Q "Receiving orphan designation from the EMA for AR-501 is an important step in ensuring the program is well positioned from a global regulatory development pathway standpoint as we continue to advance its ongoing Phase 1/2a clinical trial," Aridis CEO Vu Truong said. "We remain on track to report data from the Phase 1 segment of the trial consisting of healthy subjects in Q1 2020 and the Phase 2a portion with cystic fibrosis subjects in Q2 2021." Cystic fibrosis is a genetic disease that leaves the lungs in an imuno-compromised state, leading to frequent infections. AR-501 is being developed as a weekly inhaled treatment, and preclinical data has shown its safety when used in conjunction with antibiotics. The San Jose, California company’s stock climbed 3.2% to $10.12 on Friday. Contact Andrew Kessel at [email protected] Follow him on Twitter @andrew_kessel
Credit: Wibbitz Studio - Published < > Embed
News video: Drug Overdoses Fatalities Have Dropped in the US

Drug Overdoses Fatalities Have Dropped in the US 01:11

Drug Overdoses Fatalities Have Dropped in the US According to new data from the CDC, overdoses killed 68,500 in 2018. That's a small but welcoming drop from 72,000 in 2017. Until 2018, the number of deaths related to drug overdosing had increased each year for awhile. From 1999 to 2017, annual...

You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.